Efficacy and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% Administered Twice Daily for 3 Days in the Treatment of Bacterial Conjunctivitis: A Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study in Adults and Children

✍ Scribed by Bruce E. Silverstein; Catherine Allaire; Kirk M. Bateman; Lynne S. Gearinger; Timothy W. Morris; Timothy L. Comstock

• Book ID: 113544322
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 499 KB
• Volume: 33
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2010.12.004